JPH10287651A5 - - Google Patents

Info

Publication number
JPH10287651A5
JPH10287651A5 JP1998107161A JP10716198A JPH10287651A5 JP H10287651 A5 JPH10287651 A5 JP H10287651A5 JP 1998107161 A JP1998107161 A JP 1998107161A JP 10716198 A JP10716198 A JP 10716198A JP H10287651 A5 JPH10287651 A5 JP H10287651A5
Authority
JP
Japan
Prior art keywords
alkyl
fluorine
cooh
coor11
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998107161A
Other languages
English (en)
Japanese (ja)
Other versions
JP4234805B2 (ja
JPH10287651A (ja
Filing date
Publication date
Priority claimed from DE1998102530 external-priority patent/DE19802530A1/de
Application filed filed Critical
Publication of JPH10287651A publication Critical patent/JPH10287651A/ja
Publication of JPH10287651A5 publication Critical patent/JPH10287651A5/ja
Application granted granted Critical
Publication of JP4234805B2 publication Critical patent/JP4234805B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP10716198A 1997-04-04 1998-04-03 プロパノールアミン誘導体、それらの製法、それらを含有する薬剤およびそれらの使用 Expired - Fee Related JP4234805B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19713865 1997-04-04
DE19713865:9 1998-01-26
DE19802530:0 1998-01-26
DE1998102530 DE19802530A1 (de) 1998-01-26 1998-01-26 Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung

Publications (3)

Publication Number Publication Date
JPH10287651A JPH10287651A (ja) 1998-10-27
JPH10287651A5 true JPH10287651A5 (2) 2005-09-08
JP4234805B2 JP4234805B2 (ja) 2009-03-04

Family

ID=26035472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10716198A Expired - Fee Related JP4234805B2 (ja) 1997-04-04 1998-04-03 プロパノールアミン誘導体、それらの製法、それらを含有する薬剤およびそれらの使用

Country Status (23)

Country Link
US (1) US5874451A (2)
EP (1) EP0869121B1 (2)
JP (1) JP4234805B2 (2)
KR (1) KR19980081055A (2)
CN (1) CN1185217C (2)
AR (1) AR011210A1 (2)
AT (1) ATE268758T1 (2)
AU (1) AU730228B2 (2)
BR (1) BR9801150A (2)
CA (1) CA2233925A1 (2)
CZ (1) CZ293758B6 (2)
DE (1) DE59811528D1 (2)
DK (1) DK0869121T3 (2)
ES (1) ES2223091T3 (2)
HU (1) HUP9800781A3 (2)
ID (1) ID20137A (2)
IL (1) IL123927A (2)
MY (1) MY114944A (2)
NZ (1) NZ330110A (2)
PL (1) PL325699A1 (2)
PT (1) PT869121E (2)
RU (1) RU2198876C2 (2)
TR (1) TR199800608A2 (2)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19845402B4 (de) * 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
KR100581199B1 (ko) 1998-06-19 2006-05-17 카이론 코포레이션 글리코겐 신타제 키나제 3의 억제제
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
DE19845406C2 (de) * 1998-10-02 2001-10-18 Aventis Pharma Gmbh Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845403B4 (de) * 1998-10-02 2005-02-10 Aventis Pharma Deutschland Gmbh Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung
AU2002231688A1 (en) 2000-12-21 2002-07-01 Sanofi-Aventis Deutschland Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
PL366855A1 (en) * 2001-08-22 2005-02-07 Aventis Pharma Deutschland Gmbh Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
JP4691988B2 (ja) 2002-10-03 2011-06-01 小野薬品工業株式会社 Lpa受容体拮抗剤
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
ATE528276T1 (de) * 2003-12-19 2011-10-15 Ono Pharmaceutical Co Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen
CN1869002A (zh) * 2005-05-27 2006-11-29 中国科学院上海药物研究所 一类非甾体雄激素受体调节剂、其制备方法和用途
DK2848610T3 (da) * 2006-11-15 2017-11-06 Ym Biosciences Australia Pty Hæmmere af kinaseaktivitet
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
US20140275090A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
CN105553262B (zh) * 2015-08-24 2018-02-16 苏州瑞铬优电子科技有限公司 一种提高dc/dc升压变换器转换效率的方法
PL3923943T3 (pl) 2019-02-12 2024-12-09 Mirum Pharmaceuticals, Inc. Zależna od genotypu i dawki odpowiedź na asbti u pacjentów z niedoborem pompy eksportu soli żółciowych

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892341A7 (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanoliamiinijohdannaisia
NZ240846A (en) * 1990-12-06 1994-04-27 Hoechst Ag Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
DE4040026A1 (de) * 1990-12-14 1992-06-17 Bayer Ag Substituierte pyridyl-dihydroxy-heptensaeure und deren salze
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
DK0557879T3 (da) * 1992-02-22 1997-06-16 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler med indhold af disse forbindelser og deres anvendelse

Similar Documents

Publication Publication Date Title
JPH10287651A5 (2)
US20040259842A1 (en) Intracellular calcuim concentration increase inhibitors
JP2005508905A5 (2)
JP2006526031A5 (2)
JP2002332234A5 (2)
CA2345369A1 (en) Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
JP2004516314A5 (2)
JP2012506896A5 (2)
JP2005511698A5 (2)
JP2004514663A5 (2)
JP2008533191A5 (2)
JP2005518405A5 (2)
JP2002513793A5 (2)
JP2002030084A5 (2)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2005536519A5 (2)
JP2003503449A5 (2)
JP2002527414A5 (2)
JPWO2023195529A5 (2)
JP2002526539A5 (2)
JP2005505583A5 (2)
JP2008513510A5 (2)
JP2007515467A5 (2)
JP2004525178A5 (2)
RU2004117595A (ru) Производные пиридина в качестве лигандов рецептора nmda